Omenn syndrome

From WikiMD's Medical Encyclopedia

Revision as of 01:02, 28 May 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

autorecessive

Omenn syndrome is a rare, inherited immunodeficiency disorder characterized by severe combined immunodeficiency (SCID) with features of autoimmunity. It is named after the American pediatrician Gilbert Omenn, who first described the condition.

Presentation[edit]

Patients with Omenn syndrome typically present in early infancy with severe erythroderma, hepatosplenomegaly, lymphadenopathy, and chronic diarrhea. They also exhibit failure to thrive and recurrent, often life-threatening infections. The syndrome is associated with elevated levels of immunoglobulin E (IgE) and eosinophilia.

Pathophysiology[edit]

Omenn syndrome is caused by mutations in genes critical for the development and function of T cells and B cells. The most commonly affected genes are RAG1 and RAG2, which are essential for the recombination of antigen receptors on these cells. Mutations in these genes lead to a partial defect in V(D)J recombination, resulting in the production of autoreactive T cells and a lack of functional B cells.

Diagnosis[edit]

The diagnosis of Omenn syndrome is based on clinical presentation, laboratory findings, and genetic testing. Laboratory tests typically show elevated IgE levels, eosinophilia, and absent or low levels of circulating B cells. Genetic testing can confirm mutations in the RAG1 or RAG2 genes or other genes associated with SCID.

Treatment[edit]

The primary treatment for Omenn syndrome is hematopoietic stem cell transplantation (HSCT), which can restore normal immune function. Prior to transplantation, patients may require supportive care, including antibiotics, antifungals, and intravenous immunoglobulin (IVIG) to manage infections and other complications.

Prognosis[edit]

The prognosis for patients with Omenn syndrome has improved with advances in HSCT. Early diagnosis and treatment are critical for improving outcomes. Without treatment, the condition is usually fatal in early childhood due to severe infections and complications from autoimmunity.

See also[edit]

References[edit]

External links[edit]

-


Medical Condition
[[File:|250px|alt=|]]
Synonyms N/A
Pronounce N/A
Field N/A
Symptoms N/A
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes N/A
Risks N/A
Diagnosis N/A
Differential diagnosis N/A
Prevention N/A
Treatment N/A
Medication N/A
Prognosis N/A
Frequency N/A
Deaths N/A


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.